Frontier Bio
Information
Frontier Bio is pushing the boundaries of tissue engineering to deliver advanced solutions for combating cardiovascular disease and improving the development pathway for vascular medical devices.
Our innovative technology enables the design and creation of living blood vessels in vitro, with the ability to match the complex architectures seen in the body. These tissue-engineered blood vessels may be employed as vascular grafts, grown bespoke for individuals using their own cells, offering a potentially superior solution for arterial bypass and reconstructive surgery. Autologous vessels represent the gold standard for vascular grafting; however, these require invasive harvest and are of limited availability. Tissue engineering enables autologous vascular grafts on-demand.
Additionally, our tissue-engineered blood vessels may be used as in vitro models for vascular medical device testing, mimicking the behaviour of natural blood vessels and offering an alternative to live animal testing. The use of animal models is problematic, as these do not accurately recreate the architecture or physiology of humans and their use also raises ethical issues. Tissue-engineered blood vessels offer a superior and more ethical model system for evaluating medical device performance.
Frontier Bio is creating engineered tissues to replace animal studies and save lives. We welcome opportunities to partner with the medical device industry to help deliver our vision.